Dilution of Equity Value from the Exercise of Stock Acquisition Rights
First written in FY2024. 2 of 3 entries say "Mitigated", first in FY2025. Latest entry: FY2026.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「As of 31 May 2026, the end of the month preceding the month in which this document was filed, the number of potential shares from stock acquisition rights was 248,700, equivalent to 4.2% of the total number of issued shares including potential shares, 5,875,900.」
The potential dilution ratio declined from 7.1% to 4.2%, and the number of potential shares was 248,700. The risk of dilution from the exercise of stock acquisition rights continues to be disclosed. - FY2025MitigatedAnnual report
「As of 31 May 2025, the end of the month preceding the month in which this document was filed, the number of potential shares from stock acquisition rights was 432,900, equivalent to 7.1% of the total number of issued shares including potential shares, 6,060,100.」
While the potential share ratio declined from 7.4% in the previous fiscal year to 7.1%, the disclosure continues to identify the dilution risk from the exercise of stock acquisition rights. - FY2024First statedAnnual report
「As of 31 May 2024, the end of the month preceding the month in which this document was filed, the number of potential shares from stock acquisition rights was 452,300, equivalent to 7.4% of the total number of issued shares including potential shares, 6,079,500.」
The disclosure states that the exercise of stock acquisition rights may dilute existing shareholders' equity value and quantifies the potential shares at 452,300, or 7.4%.